It has been demonstrated that BRAF mutations resulted in increased mRNA Nrf2 levels [70]; however, accumulating evidence showed that post-translational mechanisms regulating Nrf2 protein content mainly occur in melanoma [33]. The gene discussed is BRAF; the disease is melanoma.